To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Codiak Biosciences goes public
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
